Catalyst Wire Dossier Catalyst Wire Dossier

Bifidobacterium infantis NLS super strain

Bifidobacterium infantis NLS super strain · Global Institute of Probiotics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bifidobacterium infantis NLS super strain, covering 2018-08-24 to 2018-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Bifidobacterium Infantis NLS Super Strain for Celiac Disease Patients on a Gluten-free Diet With Persistent Gastrointestinal Symptoms [Phase 2]

See pricing